All-In
Bryan Johnson: I Just Took the Most Powerful Dose of DMT in the World... Here's What It Was Like
with Bryan Johnson
26 Mar 2026
28 min read
2h 15m
TL;DR
Bryan Johnson took 5-MeO-DMT, a psychedelic 5-10x more powerful than DMT, as a longevity experiment and describes it as the most profound human experience imaginable—dissolving his default mode network and producing lasting changes in how he relates to stress, relationships, and his sense of self. His brain imaging shows psilocybin restored youthful neural connectivity patterns, though the long-term effects and risks of psychedelic-induced personality changes remain unclear.
Bryan Johnson is a biohacker and longevity researcher who founded Kernel, a company focused on brain imaging and understanding neuroscience. He previously sold his company Nootrobox and has spent the last five years systematically testing interventions backed by scientific evidence to reverse aging. Johnson has become known for his extreme self-experimentation, including taking high doses of psilocybin and 5-MeO-DMT while measuring their effects on his brain through advanced neuroimaging.
Takeaways
1
Psychedelics Show Promise as Longevity Therapy Bryan Johnson's quantified experiments with psilocybin and 5-MeO-DMT suggest psychedelics may constitute a novel class of rejuvenation therapy rather than just psychiatric treatments. His brain imaging via Kernel showed psilocybin restored youthful connectivity patterns and metabolic resets in blood glucose and microbiome. However, this remains exploratory; the durability of effects and mechanism in humans requires further study before clinical adoption.
2
Default Mode Network Dissolution Drives Behavioral Change 5-MeO-DMT appears to more completely dissolve the brain's default mode network—the system responsible for self-referential thought and rumination—compared to psilocybin's dampening effect. This dissolution correlates with reported improvements in emotional regulation, relationship dynamics, and childlike wonder. The persistence and reversibility of this rewiring remain unknown, creating both therapeutic potential and risk of unwanted personality shifts.
3
Psychedelics Demand Rigorous Set, Setting, and Supervision Johnson emphasizes that recreational psychedelic use—unquantified doses, uncontrolled environments, untrained guides—likely explains adverse outcomes like persistent bad trips and induced psychosis. Proper deployment requires clinical supervision, correct set and setting, appropriate candidate screening, and measured dosing. His 48-hour livestreamed 5-MeO experience with professional oversight demonstrates a model for safer exploration, though systemic risks like life-altering perspective shifts remain for high-functioning individuals.